• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Capsulomics Expands Leadership Team with Key Hires


Capsulomics, Inc., a life sciences company focused on the development and commercialization of diagnostic solutions for cancer screening, prevention, and smarter treatment decisions, announced today the appointment of Stacey Gilbert as Vice President of Market Access and Reimbursement, and Lisa Kann as Vice President of Product Development and Strategy.

"I am thrilled to welcome these industry leaders to the Capsulomics team," said Daniel Lunz, Capsulomics' CEO. "Stacey and Lisa bring exceptional experience, developing and commercially launching some of the most successful diagnostic products available today. Their leadership will serve Capsulomics well as we near the launch of our first product."

Related Videos
Related Content